UPDRS Part III

Related by string. * : Rating Scale UPDRS . UPDRS II . UPDRS scores . UPDRS motor . UPDRS / parter . parting . parts . PART . parted . Parts : PART BY ITS NEGLIGENCE . PART OF ANY OTHER . NO PART OF . WARRANTIES PARTS OR ALL . Hangover Part II . Advance Auto Parts / Iii . iii . IIIs . IIID . IIi : Star Wars Episode III . Phase III clinical trials . Phase III trials . Phase III clinical . Guitar Hero III * *

Related by context. Frequent words. (Click for all words.) 74 Unified Parkinson Disease 70 UPDRS 60 Secondary endpoints include 59 sensory neuropathy 59 Severity Index PASI 58 ADAS cog 58 Alzheimer Disease Assessment 58 Secondary endpoints included 58 Psoriasis Area 58 Health Assessment Questionnaire 57 Montgomery Asberg Depression 57 Main Outcome Measures 57 PANSS 56 HRQL 56 Visual Analog Scale 56 Disease Activity 55 Negative Syndrome 55 clinically meaningful improvement 55 International Prostate Symptom 55 Postoperative 55 Secondary endpoints 55 estimated glomerular filtration 55 dyspnoea 54 HRQoL 54 neurocognitive function 54 extrapyramidal symptoms 54 Rating Scale MADRS 54 CDAI 54 symptom severity 53 ADHD Rating Scale 53 Rating Scale 53 WOMAC 53 Expanded Disability Status 53 psychosocial functioning 53 Natural Catastrophe Stress 53 EQ 5D 53 content VENDOR WHITE PAPER 53 cerebrovascular accident 52 MMSE 52 Thrombolysis 52 multivariate logistic regression 52 HRQOL 52 ADHD RS 51 vWF 51 Sleepiness 51 Comorbidity 51 DAS# [002] 51 pericardial effusion 51 Ischemic 51 Myocardial 51 PsA 51 hypophosphatemia 51 MADRS 51 myocardial perfusion 51 posttreatment 51 Cognitive Function 50 Alzheimer Disease Cooperative 50 univariate 50 CIMZIA TM 50 fasting insulin 50 subscales 50 neutropenia thrombocytopenia 50 TEAEs 50 neovascular 50 mortality morbidity 50 IPSS 50 Exacerbations 49 apnea hypopnea index 49 Elderly Patients 49 pruritis 49 erythrocyte sedimentation rate 49 generalized anxiety disorder GAD 49 active ankylosing spondylitis 49 daytime sleepiness 49 Spasticity 49 sensorless 49 Confirmatory 49 POAG 49 hypercholesterolaemia 49 8 CYL 49 VKORC1 49 QTc prolongation 49 Cognitive Impairment 49 % CI #.#-#.# [007] 49 inattention hyperactivity 49 somatic symptoms 49 Global Impression 49 primary percutaneous coronary 49 Operating Expenses Operation 49 subthreshold 49 psychiatric morbidity 49 alanine aminotransferase 48 QoL 48 Significantly Improved 48 Mini Mental 48 Pharmacokinetic 48 Pharmacologic 48 Lung Function 48 Neuropsychological 48 severities 48 histopathological

Back to home page